CVE-2026-31070: LalanaChami Pharmacy Management System · CVE-2026-31070 is a critical
Source CVE Database V5
Not known to be exploited · CVSS 9.8 Critical.
Data as of 27 Oct 2026, 05:11 UTC
- EPSS
- 0.4% chance of exploitation in 30 days – higher than 40% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:HExploitation evidence
Disclosed: evidence found.
CVE published 19 May 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.
What to do
AI-suggested
Until an official fix is available, restrict access to the signup endpoint if possible, and monitor for suspicious registration activity. Do not rely on client-side or superficial validation of role parameters. Implement server-side validation to enforce proper role assignment during user registration.
Description
CVE-2026-31070 is a critical vulnerability in the LalanaChami Pharmacy Management System that allows unauthenticated remote attackers to escalate privileges by assigning themselves an administrative role during user registration. This occurs because the /api/user/signup endpoint does not validate the role parameter in the request body, enabling privilege escalation without authentication.